Clinical Trials
5
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:3
Phase 3:1
Drug Approvals
5
FDA:3
CANADA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 3
1 (25.0%)Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite
Phase 2
Withdrawn
- Conditions
- COVID-19Acute Respiratory Distress SyndromeAcute Respiratory Failure
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2020-05-26
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Hope Pharmaceuticals
- Registration Number
- NCT04401527
- Locations
- 🇺🇸
Participating Research Facility, Fort Worth, Texas, United States
Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
Terminated
- Conditions
- Calciphylaxis
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2018-11-20
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 5
- Registration Number
- NCT03319914
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Veterans Administration Medical Center, Albany, New York, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients
Phase 3
Terminated
- Conditions
- Calciphylaxis
- Interventions
- Drug: Placebo-Normal Saline
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 29
- Registration Number
- NCT03150420
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸Northwestern University Hospital, Chicago, Illinois, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2018-03-30
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 6
- Registration Number
- NCT02176837
- Locations
- 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 19
- Registration Number
- NCT00873015
- Locations
- 🇺🇸
University of Virginia Health System Medical Center, Charlottesville, Virginia, United States
News
No news found